title: The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone.
abstract: In a placebo controlled trial, the effect of the M1-antagonist telenzepine (3 mg in the morning) and of the dopamine antagonist domperidone (10 mg t.d.s.) was studied on bowel habits, on oro-caecal and on oro-anal transit time. The study was carried out on healthy subjects double-blind, multiple cross-over. The test periods were seven days each interrupted by wash-out periods of seven days. Stool weight, frequency and consistency as well as side-effects were recorded daily. The oro-anal transit time was estimated by evaluating the excretion of orally ingested radiopaque markers. The oro-caecal transit time was studied by means of a hydrogen breath test after a standard meal. The oro-caecal transit time was significantly prolonged during medication with telenzepine, both compared with placebo (p less than 0.05) and with domperidone (p less than 0.01). Bowel habits and the oro-anal transit time remained statistically unchanged during treatment with the active drugs. It is concluded that telenzepine has a dissociate effect on intestinal motility, delaying transit through the upper gastrointestinal tract without affecting the oro-anal transit time.
authors.affiliation: Marbachtalklinik, Bad Kissingen.
authors.forename: U
authors.initials: U
authors.lastname: Armbrecht
authors.forename: W
authors.initials: W
authors.lastname: Reul
authors.forename: R W
authors.initials: RW
authors.lastname: Stockbrügger
mesh_terms: D000293:Adolescent; D000328:Adult; D004294:Domperidone / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D005772:Gastrointestinal Transit / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000294:innervation; D010276:Parasympatholytics / Q000494:pharmacology*; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D011954:Receptors, Dopamine / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects
chemical_list: D010276:Parasympatholytics; D011954:Receptors, Dopamine; D011976:Receptors, Muscarinic; C046338:telenzepine; D010890:Pirenzepine; D004294:Domperidone